by PRI | Jul 15, 2022 | News & Events
On 14 July 2022 the European Commission published a draft proposal of its revision to the Blood Tissues and Cells (BTC) legislative framework. Following the announcement of the revision to the BTC legislation in 2019, it became apparent that this updated legislation...
by PRI | Jul 7, 2022 | News & Events
The microbiome field is suffering from limited reproducibility and comparability between studies, especially in large human cohorts. This lack of reproducibility and comparability is a major hurdle in the emergence of microbiome-based biomarkers. The emergence of...
by PRI | Jun 17, 2022 | News & Events
On 13 June 2022 the EU-Innovation Network (jointly coordinated by the European Medicines Agency – EMA, and the Heads of Medicines Agencies – HMA) published a Horizon Scanning Report on Faecal Microbiota Transplantation. The report describes the use of...
by PRI | Jun 11, 2022 | News & Events
Following our announcement in February that we were recruiting a new member to the PRI Staff, we are pleased to announce that Dr. Julie Rodriguez (PhD) accepted to join the PRI as our new OMICS Project Manager. Julie Rodriguez obtained her PhD degree in Physiology,...
by PRI | Apr 25, 2022 | News & Events
The Pharmabiotics 2022 Conference & Partnering Event was held on 20-21 April 2022 in Lyon, France. Nearly 200 delegates from industry and academia joined together to discuss a range of topics focusing on microbiome regulatory science, multi-omics standardization...
by PRI | Jun 1, 2021 | News & Events
The PRI has been invited to join as a core partner the Human Microbiome Action consortium (https://humanmicrobiomeaction.eu/). As Europe’s Microbiome Regulatory Science expertise center, we are co-leading a transversal work package on Ethics & Regulatory which has...
